162 related articles for article (PubMed ID: 23330571)
1. Is psychotic disorder associated with increased levels of craving for cannabis? An Experience Sampling study.
Kuepper R; Oorschot M; Myin-Germeys I; Smits M; van Os J; Henquet C
Acta Psychiatr Scand; 2013 Dec; 128(6):448-56. PubMed ID: 23330571
[TBL] [Abstract][Full Text] [Related]
2. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
Machielsen M; van der Sluis S; de Haan L
Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
[TBL] [Abstract][Full Text] [Related]
3. Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls.
Dekker N; Smeerdijk AM; Wiers RW; Duits JH; van Gelder G; Houben K; Schippers G; Linszen DH; de Haan L
Psychol Med; 2010 Aug; 40(8):1325-36. PubMed ID: 19917142
[TBL] [Abstract][Full Text] [Related]
4. Craving for cannabis in patients with psychotic disorder, their non-affected siblings and healthy controls: psychometric analysis of the obsessive compulsive drug use scale.
Dekker N; Koeter M; Van Den Brink W;
Int J Methods Psychiatr Res; 2012 Dec; 21(4):286-300. PubMed ID: 22961922
[TBL] [Abstract][Full Text] [Related]
5. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
[TBL] [Abstract][Full Text] [Related]
6. Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis.
Barrigón ML; Gurpegui M; Ruiz-Veguilla M; Diaz FJ; Anguita M; Sarramea F; Cervilla J
J Psychiatr Res; 2010 May; 44(7):413-20. PubMed ID: 19900684
[TBL] [Abstract][Full Text] [Related]
7. COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life.
Henquet C; Rosa A; Delespaul P; Papiol S; Fananás L; van Os J; Myin-Germeys I
Acta Psychiatr Scand; 2009 Feb; 119(2):156-60. PubMed ID: 18808401
[TBL] [Abstract][Full Text] [Related]
8. Delusions incorporating cannabis use in dually diagnosed patients with a primary psychotic disorder.
Flanders SE
Aust N Z J Psychiatry; 2007 Nov; 41(11):934-6. PubMed ID: 17924247
[TBL] [Abstract][Full Text] [Related]
9. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study.
Verdoux H; Gindre C; Sorbara F; Tournier M; Swendsen JD
Psychol Med; 2003 Jan; 33(1):23-32. PubMed ID: 12537033
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and symptomatological features in chronic psychotic patients according to cannabis use status.
Maremmani I; Lazzeri A; Pacini M; Lovrecic M; Placidi GF; Perugi G
J Psychoactive Drugs; 2004 Jun; 36(2):235-41. PubMed ID: 15369205
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics influencing age at onset in psychotic disorders.
Ongür D; Lin L; Cohen BM
Compr Psychiatry; 2009; 50(1):13-9. PubMed ID: 19059508
[TBL] [Abstract][Full Text] [Related]
12. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
13. Momentary assessment research in psychosis.
Oorschot M; Kwapil T; Delespaul P; Myin-Germeys I
Psychol Assess; 2009 Dec; 21(4):498-505. PubMed ID: 19947784
[TBL] [Abstract][Full Text] [Related]
14. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.
Corcoran CM; Kimhy D; Stanford A; Khan S; Walsh J; Thompson J; Schobel S; Harkavy-Friedman J; Goetz R; Colibazzi T; Cressman V; Malaspina D
Schizophr Res; 2008 Dec; 106(2-3):286-93. PubMed ID: 18809298
[TBL] [Abstract][Full Text] [Related]
15. Cannabis abuse and severity of psychotic and affective disorders in Israeli psychiatric inpatients.
Katz G; Durst R; Shufman E; Bar-Hamburger R; Grunhaus L
Compr Psychiatry; 2010; 51(1):37-41. PubMed ID: 19932824
[TBL] [Abstract][Full Text] [Related]
16. Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort.
Manrique-Garcia E; Zammit S; Dalman C; Hemmingsson T; Andreasson S; Allebeck P
Psychol Med; 2012 Jun; 42(6):1321-8. PubMed ID: 21999906
[TBL] [Abstract][Full Text] [Related]
17. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
[TBL] [Abstract][Full Text] [Related]
18. [Related, induced and associated psychiatric disorders to cannabis].
Laqueille X
Rev Prat; 2005 Jan; 55(1):30-4. PubMed ID: 15801394
[TBL] [Abstract][Full Text] [Related]
19. Cannabis use in psychotic patients.
Sembhi S; Lee JW
Aust N Z J Psychiatry; 1999 Aug; 33(4):529-32. PubMed ID: 10483847
[TBL] [Abstract][Full Text] [Related]
20. Reflection impulsivity and response inhibition in first-episode psychosis: relationship to cannabis use.
Huddy VC; Clark L; Harrison I; Ron MA; Moutoussis M; Barnes TR; Joyce EM
Psychol Med; 2013 Oct; 43(10):2097-107. PubMed ID: 23339857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
